Autoantibodies / (Record no. 9278)

MARC details
000 -LEADER
fixed length control field 05704pam a2200277 a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230925052527.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 960312s1996 ne a b 001 0 eng c
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0444823832
040 ## - CATALOGING SOURCE
Original cataloging agency BUL
Transcribing agency BUL
Modifying agency BUL
Language of cataloging eng
Description conventions rda
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number QW 575.5 A8 A939 1996
Item number A8 A939 1996
245 00 - TITLE STATEMENT
Title Autoantibodies /
Statement of responsibility, etc. editors, James B. Peter, Yehuda Shoenfeld.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Amsterdam ;
-- New York :
Name of publisher, distributor, etc. Elsevier,
Date of publication, distribution, etc. 1996.
300 ## - PHYSICAL DESCRIPTION
Extent xxix, 880 p. :
Other physical details ill. ;
Dimensions 27 cm.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Contents<br/><br/>Foreword:The Uses of Autoantibodies. <br/>Acetylcholine Receptor Autoantibodies. <br/>Actin Autoantibodies.<br/>Affinity and Avidity of Autoantibodies. <br/>Alpha-Galactosyl (ANTI-GAL) Autoantibodies. <br/>Aminoacyl-tRNAHistidyl (Jo-1) Synthetase Autoantibodies. <br/>Aminoacyl-tRNA (other than Histidyl) Synthetase Autoantibodies. <br/>Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Diseases. <br/>Antineutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase. <br/>Antineutrophil Cytoplasmic Autoantibodies withSpecificity for Proteinase 3. <br/>Antineutrophil Cytoplasmic Autoantibodies with Specificity other than PR3 and MPO (X-ANCA). <br/>Antinuclear Antibodies.<br/> Autoantibodies in Therapeutic Preparations of Human IgG (IVIg). <br/>Autoantibodies that Penetrate into Living Cells. <br/>Autoantibody Subclasses. <br/>B2-Glycoprotein I Autoantibodies. <br/>Beta-Adrenergic Receptor (and other hormone receptor) Autoantibodies. <br/>Bromelain-treated ErythrocyteAutoantibodies. <br/>C1 Inhibitor Autoantibodies. <br/>C1q Autoantibodies. <br/>Calcium Channel and Related Paraneoplastic Disease Autoantibodies. <br/>Calcium Channel Autoantibodies and Amyotrophic Lateral Sclerosis. <br/>Centriole and Centrosome Autoantibodies. <br/>Centromere Autoantibodies. <br/>Chromo Autoantibodies. <br/>CoagulationFactor VIII Autoantibodies. <br/>Coagulation Factor (excluding Factor VIII) Autoantibodies. <br/>Collagen Autoantibodies. <br/>Cryoglobulins. <br/>Cryoglobulins Secondary to Hepatitis C Virus Infection. <br/>Cytokine Autoantibodies. Cytoskeletal Autoantibodies. <br/>dsDNA Autoantibodies. <br/>Endomysial Autoantibodies. <br/>Endothelial Cell Autoantibodies. <br/>Fibrillarin Autoantibodies. <br/>Fibronectin Autoantibodies. <br/>56-kd Nuclear Protein Autoantibodies. <br/>Filaggrin (Keratin) Autoantibodies. <br/>Ganglioside Autoantibodies. <br/>Gliadin Antibodies. <br/>Glomerular Basement Membrane Autoantibodies. <br/>Glutamic Acid Decarboxylase Autoantibodies in DiabetesMellitus. <br/>Glutamic Acid Decarboxylase Autoantibodies in Stiff-Man Syndrome. <br/>Glycolipid (excluding Ganglioside) Autoantibodies. <br/>Golgi Apparatus Autoantibodies. <br/>Granulocyte-Specific Antinuclear Antibodies. <br/>Heat Shock Protein Autoantibodies. <br/>Heparin-Associated Autoantibodies. <br/>Heterophile Antibodies. <br/>Hidden Autoantibodies. <br/>Histone (H2A-H2B)-DNA Autoantibodies. <br/>Histone Autoantibodies other than (H2A-H2B)- DNA Autoantibodies. <br/>Hormone Nonpeptide Autoantibodies: THYROID. <br/>Hormone Peptide Autoantibodies. <br/>Human Antimouse Antibodies. <br/>Idiotypes and Anti-Idiotypic Antibodies. <br/>IgA Autoantibodies. <br/>IgE Receptor Autoantibodies. <br/>Insulin Autoantibodies. <br/>Interferon-Inducible Protein IFI 16 Autoantibodies. <br/>Islet Cell Autoantibodies. <br/>Ku and Ki Autoantibodies. <br/>Liver Cytosol Antigen Type 1 Autoantibodies. <br/>Liver/Kidney Microsomal Autoantibodies. <br/>Liver Membrane Autoantibodies. <br/>Lupus Anticoagulant. <br/>Lymphocytotoxic Autoantibodies. <br/>Mi-2 Autoantibodies. <br/>Mitochondrial Autoantibodies. <br/>Mitotic Spindle Apparatus Autoantibodies. <br/>Molecular Mimicry. <br/>Myelin-Associated Glycoprotein Autoantibodies. <br/>Myelin Basic ProteinAutoantibodies. <br/>Myocardial Autoantibodies. <br/>Natural Autoantibodies. <br/>Nephritic Factor Autoantibodies. <br/>Neuronal Autoantibodies. <br/>Neuronal Nuclear Autoantibodies, Type 1 (Hu). <br/>Neutrophil Autoantibodies. <br/>Nuclear Envelope Protein Autoantibodies. <br/>Nucleolar Autoantibodies. <br/>Nucleosome-Specific Autoantibodies. <br/>Other Autoantibodies to Nuclear Antigens. <br/>p53 Autoantibodies. <br/>Parietal Cell Autoantibodies. <br/>Pathogenic Mechanisms. <br/>Perinuclear Factor (Profilaggrin) Autoantibodies. <br/>Phospholipid Autoantibodies - Cardiolipin.Phospholipid Autoantibodies - Phosphatidylserine. <br/>Platelet Autoantibodies. <br/>PM-SCL Autoantibodies. <br/>Proliferating Cell Nuclear Antigen Autoantibodies. <br/>Purkinje Cell Autoantibodies, TYPE 1 (Yo). RA-33 (Heterogeneous Nuclear Ribonucleoprotein Complex) Autoantibodies. <br/>Recombinant Autoantigens. <br/>Red CellAutoantibodies. <br/>Reticulin Autoantibodies. <br/>Retinal Autoantibodies. <br/>Retroviral Antibodies. <br/>Rheumatoid Factors. <br/>Ribosomal Autoantibodies. <br/>Ribosomal P Protein Autoantibodies. <br/>RNA Polymerase I-III Autoantibodies. <br/>Signal Recognition Particle Autoantibodies. <br/>Silicate and Silicone Antibodies. <br/>Skin Diseases Autoantibodies. <br/>Smooth Muscle Autoantibodies. <br/>Spliceosomal snRNPS Autoantibodies. <br/>SS-A (Ro) Autoantibodies. <br/>SS-B (La) Autoantibodies. <br/>Steroid Cell Autoantibodies. <br/>Striational Autoantibodies. <br/>Thyroglobulin Autoantibodies.<br/>Thyroid Peroxidase Autoantibodies. <br/>Thyrotropin Receptor Autoantibodies. <br/>Topoisomerase-I (Scl-70) Autoantibodies. <br/>Tubular Basement Membrane Autoantibodies. <br/>Tyrosinase Autoantibodies. <br/>Xenoreactive Human Natural Antibodies.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Autoantibodies.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Autoantibodies.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Autoimmune Diseases
General subdivision etiology.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Peter, James B.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shoenfeld, Yehuda.
856 42 - ELECTRONIC LOCATION AND ACCESS
Materials specified Publisher description
Uniform Resource Identifier <a href="http://www.loc.gov/catdir/enhancements/fy0601/96013604-d.html">http://www.loc.gov/catdir/enhancements/fy0601/96013604-d.html</a>
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
a 7
b cbc
c orignew
d 1
e ocip
f 19
g y-gencatlg
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Book Open Access
Classification part QW 575.5 A8 A939 1996
Item part 1
Call number prefix QW 575.5
Call number suffix A8 A939 1996
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Source of acquisition Inventory number Total Checkouts Full call number Barcode Date last seen Copy number Price effective from Koha item type
    Dewey Decimal Classification     Health Sciences Library Health Sciences Library 01/20/2022 Donation 00583   QW 575.5 A8 A939 1996 MBAL22010840 01/20/2022 1 01/20/2022 Book Open Access